390 related articles for article (PubMed ID: 27638713)
1. Gene therapy targeting mitochondrial pathway in Parkinson's disease.
Choong CJ; Mochizuki H
J Neural Transm (Vienna); 2017 Feb; 124(2):193-207. PubMed ID: 27638713
[TBL] [Abstract][Full Text] [Related]
2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction in Parkinson's disease.
Bose A; Beal MF
J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
[TBL] [Abstract][Full Text] [Related]
4. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
Koentjoro B; Park JS; Sue CM
Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
[TBL] [Abstract][Full Text] [Related]
5. Mitophagy and Parkinson's disease: be eaten to stay healthy.
de Vries RL; Przedborski S
Mol Cell Neurosci; 2013 Jul; 55():37-43. PubMed ID: 22926193
[TBL] [Abstract][Full Text] [Related]
6. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial kinase PINK1: functions beyond mitophagy.
Voigt A; Berlemann LA; Winklhofer KF
J Neurochem; 2016 Oct; 139 Suppl 1():232-239. PubMed ID: 27251035
[TBL] [Abstract][Full Text] [Related]
8. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
9. S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models.
Oh CK; Sultan A; Platzer J; Dolatabadi N; Soldner F; McClatchy DB; Diedrich JK; Yates JR; Ambasudhan R; Nakamura T; Jaenisch R; Lipton SA
Cell Rep; 2017 Nov; 21(8):2171-2182. PubMed ID: 29166608
[TBL] [Abstract][Full Text] [Related]
10. Parkin gene therapy.
Mochizuki H
Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S43-5. PubMed ID: 19131043
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial-Associated Membranes in Parkinson's Disease.
Hattori N; Arano T; Hatano T; Mori A; Imai Y
Adv Exp Med Biol; 2017; 997():157-169. PubMed ID: 28815529
[TBL] [Abstract][Full Text] [Related]
12. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
13. SUMO-regulated mitochondrial function in Parkinson's disease.
Guerra de Souza AC; Prediger RD; Cimarosti H
J Neurochem; 2016 Jun; 137(5):673-86. PubMed ID: 26932327
[TBL] [Abstract][Full Text] [Related]
14. Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha.
Siddiqui A; Rane A; Rajagopalan S; Chinta SJ; Andersen JK
Neurobiol Dis; 2016 Sep; 93():115-20. PubMed ID: 27185595
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial metabolism modulation: a new therapeutic approach for Parkinson's disease.
Arduíno DM; Esteves AR; Oliveira CR; Cardoso SM
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):105-19. PubMed ID: 20201821
[TBL] [Abstract][Full Text] [Related]
16. Mitophagy: the latest problem for Parkinson's disease.
Vives-Bauza C; Przedborski S
Trends Mol Med; 2011 Mar; 17(3):158-65. PubMed ID: 21146459
[TBL] [Abstract][Full Text] [Related]
17. Regulation by mitophagy.
Hattori N; Saiki S; Imai Y
Int J Biochem Cell Biol; 2014 Aug; 53():147-50. PubMed ID: 24842103
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.
Büeler H
Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004
[TBL] [Abstract][Full Text] [Related]
19. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease.
Ferretta A; Gaballo A; Tanzarella P; Piccoli C; Capitanio N; Nico B; Annese T; Di Paola M; Dell'aquila C; De Mari M; Ferranini E; Bonifati V; Pacelli C; Cocco T
Biochim Biophys Acta; 2014 Jul; 1842(7):902-15. PubMed ID: 24582596
[TBL] [Abstract][Full Text] [Related]
20. Molecular insights into Parkinson's disease.
Rochet JC; Hay BA; Guo M
Prog Mol Biol Transl Sci; 2012; 107():125-88. PubMed ID: 22482450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
